Codex DNA to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022
August 02 2022 - 4:05PM
Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop
synthetic biology systems, today announced that it will release its
second quarter 2022 financial results on Tuesday, August 9, 2022,
after the market closes. In conjunction with the release,
management will host a conference call on Tuesday, August 9, 2022,
at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the
financial results and recent corporate highlights.
The press release and live audio webcast can be
accessed via the Investors section of Codex DNA’s website at
www.codexdna.com. The conference call can be accessed by
registering at the following link:
https://register.vevent.com/register/BI3c5895f666544e6abb6418b1b284105e.
Please log in approximately 5 to 10 minutes before the event to
ensure a timely connection. Upon registration, all telephone
participants will receive the dial-in number along with a unique
PIN number that can be used to access the call. A replay of the
conference call webcast will be archived on the Codex DNA's website
for at least 30 days.
About Codex DNACodex DNA is
empowering scientists with the ability to create novel, synthetic
biology-enabled solutions for many of humanity’s greatest
challenges. As inventors of the industry-standard Gibson Assembly®
method and the first commercial automated benchtop DNA and mRNA
synthesis system, Codex DNA is enabling rapid, accurate and
reproducible writing of DNA and mRNA for numerous downstream
markets. The award-winning BioXp™ system consolidates, automates,
and optimizes the entire synthesis, cloning and amplification
workflow. As a result, it delivers virtually error-free synthesis
of DNA and RNA at scale within days and hours instead of weeks or
months. Scientists around the world are using the technology in
their own laboratories to accelerate the design-build-test paradigm
for novel, high-value products for precision medicine, biologics
drug discovery, vaccine and therapeutic development, genome
editing, and cell and gene therapy. Codex DNA is a public company
based in San Diego. For more information, visit codexdna.com.
Codex DNA, the Codex DNA logo, Gibson Assembly,
and BioXp are trademarks of Codex DNA Inc.
Contact:Brent HunterVice President of
Finance(815) 780-0842finance@codexdna.com
Codex DNA (NASDAQ:DNAY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Codex DNA (NASDAQ:DNAY)
Historical Stock Chart
From Oct 2023 to Oct 2024